Epidemiology of pneumococcal infections in the elderly

Drugs and Aging

Volumn 15, Issue SUPPL. 1, 1999, Pages 11-19

  Butler, Jay C ^a,c   Schuchat, Anne ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PENICILLIN G;

ABORIGINE; AGED; AMERICAN INDIAN; BACTEREMIA; CANADA; CAUSE OF DEATH; EUROPE; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; INFLUENZA; MENINGITIS; MORTALITY; NEGRO; PRIORITY JOURNAL; RACE; RESPIRATORY TRACT INFECTION; REVIEW; SOCIAL STATUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0033399598     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199915001-00002     Document Type: Review

References (72)

1. Marrie TJ. Community-acquired pneumonia: epidemiology, etiology, treatment. Infect Dis Clin North Am 1998; 12: 723-40
2. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337 (14): 970-6
3. Sutliff WD, Finland M. Type 1 pneumococcal infections with especial reference to specific serum treatment. N Engl J Med 1934; 210: 237-45
4. Tilghman RC, Finland M. Clinical significance of bacteremia in pneumococcal pneumonia. Arch Intern Med 1937; 59: 602-19
5. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-76
6. Breiman RF, Spika JS, Navarro VJ, et al. Pneumococcal bacteremia in Charleston County, South Carolina. Arch Intern Med 1990; 150: 1401-5
7. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health 1992; 82: 1513-6
8. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptotoccus pneumoniae: implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA 1996; 275(3): 194-8
9. Feikin D, Schuchat A, Kolczak M, et al. Mortality for invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health. In Press
10. Sankilampi U, Herva E, Haikala R, et al. Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect 1997; 118: 7-15
11. Nielsen SV, Henrichsen J. Incidence of pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect 1996; 117: 411-6
12. Zangwill KM, Vadheim CM, Vannier AM, et al. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996; 174: 752-9
13. Raz R, Elhanan G, Shimoni Z, et al. Pneumococcal hacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group. Clin Infect Dis 1997; 24: 1164-8
14. Fedson DS, Musher DM, Eskola J. Pneumococcal vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd ed. Philadelphia: WB Saunders, 1999: 553-607
15. McGeer A, Landry L, Goldenberg E, et al. Population-based surveillance for invasive pneumococcal infections in Toronto, Canada: implications for prevention [abstract no. K9]. Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1996 Sep 15-18: New Orleans, Louisiana. Washington DC: American Society for Microbiology, 1996: 251
16. Pastor P, Medley F, Murphy TV. Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995. Clin infect Dis 1998; 26: 590-5
17. George R, Efstratiou A, Broughton K, et al. Invasive pneumococcal infection in England and Wales during 1996 [abstract no. P-110]. International Symposium on Pneumococci and Pneumococcal Diseases; 1998 Jun 13-17; Helsingør, Denmark: 40
18. Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/ncidod/dbmd/abcs/ [Accessed 1999: Mar 8]
19. Smith MD, Stuart J, Andrews NJ, et al. Invasive pneumococcal infection in South and West England. Epidemiol Infect 1996; 120: 117-23
20. Schonheyder HC, Sorensen HT, Kristensen B, et al. Reasons for increase in pneumococcal bacteraemia. Lancet 1997; 349: 1554
21. Butler JC, Cetron MS, Schuchat A, et al. Invasive pneumococcal infections in the US: geographic differences in incidence and drug resistance [abstract no. 2-14:30]. International Symposium on Pneumococci and Pneumococcal Diseases; 1998 Jun 13-17: Helsinger, Denmark: 28
22. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333: 481-6
23. Cortese MM, Wolff M, Almeido-Hill J, et al. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med 1992; 152: 2277-82
24. Davidson M, Parkinson AJ, Bulkow LR, et al. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 - ethnic differences and opportunities for prevention. J Infect Dis 1994; 170: 368-76
25. Torzillo PJ, Hanna JN, Morey F, et al. Invasive pneumococcal disease in central Australia. Med J Aust 1995; 162: 182-6
26. Trotman J, Hughes B, Mollison L. Invasive pneumococcal disease in central Australia. Clin Infect Dis 1995; 20: 1553-6
27. Chen FM, Breiman RF, Farley M, et al. Geocoding and linking data from population-based surveillance and the US census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. Am J Epidemiol 1998; 148: 1212-8
28. Smillie WG, Warnock GH, White HJ. A study of type I pneumococcus epidemic at the state hospital at Worcester, Mass. Am J Pub Health 1938; 28: 293-302
29. Kim PE, Musher DM, Glezen WP, et al. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis 1996; 22: 100-6
30. Patriarca PA, Cox NJ. Influenza pandemic preparedness plan for the United States. J Infect Dis 1997; 176 Suppl. 1: S4-7
31. Fiore AE, Iverson C, Messmer T, et al. Outbreak of pneumonia in a long-term care facility: antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia. J Am Geriatr Soc 1998; 46: 1112-7
32. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46 (RR-8): 1-24
33. Redd SC, Rutherford GW, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bactercmia in San Francisco residents. J Infect Dis 1990; 162: 1012-7
34. Nuorti P, Vugia D, Butler J, et al. Invasive pneumococcal disease among HIV-infected and uninfected residents of San Francisco, California [abstract no. 540]. Program and Abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America; 1997 Sep 13-16: San Francisco, California: 172
35. Chico HY, Ries KM, Sande MA. AIDS and the elderly. Clin Infect Dis 1999; 28: 740-5
36. Chen HX, Ryan PA, Ferguson RP, et al. Characteristics of acquired immunodeficiency syndrome in older adults. J Am Geriatr Soc 1998; 46: 153-6
37. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989; 11: 586-99
38. Community-acquired pneumonia in adults in British hospitals in 1982-83: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Q J Med 1987; 62 (239): 195-220
39. Holmberg H. Aetiology of community-acquired pneumonia in hospital-treated patients. Scand J Infect Dis 1987; 19: 491-501
40. Burman LA, Trollfors B, Andersson B, et al. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis 1991; 163: 1087-93
41. Kurashi NY, al-Hamdan A, Ibrahim EM, et al. Community acquired acute bacterial and atypical pneumonia in Saudi Arabia. Thorax 1992; 47: 115-3
42. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992; 101: 1005-12
43. Blanquer J, Blanquer R, Borrás R, et al. Aetiology of community acquired pneumonia in Valencia, Spain: a mullicentre prospective study. Thorax 1991; 46: 508-11
44. Fang G-D, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective study of 359 cases. Medicine 1990; 69: 307-16
45. Kauppinen MT, Herva E, Kujala P, et al. The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 1995; 172: 1330-5
46. Moine P, Vercken JB, Chevrel S, et al. Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. Chest 1994; 105: 1487-95
47. Aderaye G. Community acquired pneumonia in adults in Addis Ababa: etiologic agents, clinical and radiographic presentation. Ethiop Med J 1994; 32: 115-23
48. Boonsawal W, Boonma P, Tangdajahiran T, et al. Community-acquired pneumonia in adults at Srinagarind Hospital. J Med Assoc Thai 1990; 73 (6): 345-52
49. Lim I, Shaw DR, Stanley DP, et al. A prospective hospital study of the etiology of community-acquired pneumonia. Med J Aust 1989; 151: 87-91
50. Mundy LM, Auwaerter PG, Oldach D, et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995; 152 (4 Pt 1): 1309-15
51. Seedat MA, Feldman C, Skoularigis J, et al. A study of acute community-acquired pneumonia, including details of cardiac-changes. Q J Med 1993; 86 (10): 669-75
52. Steinhoff D, Lode H, Ruckdeschel G, et al. Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalised patients in Berlin. Clin Infect Dis 1996; 22: 958-64
53. Marston BJ, Plouffe JF, File TM, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of population-based active surveillance in Ohio. Arch Intern Med 1997; 157: 1709-18
54. Lieberman D, Schlaeffer F, Boldur I, et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996; 51: 179-84
55. Bohte R, van Furth R, van den Brock PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995; 50: 543-7
56. Klugman KP. Antimicrobial resistance. Pneumococcal Vaccines for the World 1998 Conference; 1998 Oct 12-14: Washington DC: 13
57. Naraqi S, Kirkpatrick GP, Kahins S. Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin. J Pediatr 1974; 85: 671-3
58. Cates KL, Gerrard JM, Giebink GS, et al. A penicillin-resistant pneumococcus. J Pediatr 1978; 93: 624-6
59. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multi-drug resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995; 14: 745-50
60. Arnold KE, Leggiadro RJ, Breiman RF, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr 1996; 128: 757-64
61. Breiman RF, Butler JC, Tenover FC, et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271: 1831-5
62. Butler JC, Cetron MS. Pneumococcal drug resistance: the new 'special enemy of old age'. Clin Infect Dis 1999; 28: 730-5
63. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998; 338: 1861-8
64. Pallares R, Liñares J, Vadillo M, et al. Resistance to penicillin and cephalosporins and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-80
65. Hoge CW, Reichler MR, Dominguez EA, et al, Epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med 1994; 331: 643-8
66. Musher DM, Groover JE, Reichler MR, et al. Emergence of antibody to capsular polysaccharides of Streptococcus pneumnnine during outbreaks of pneumonia: association with nasopharyngeal colonisation. Clin Infect Dis 1997; 24: 441-6
67. Riedo F, Schwartz B, Giono S, et al. Pneumococcal pneumonia outbreak in a ranger training battalion, Georgia [abstract no. 48]. Program and Abstracts of the 31st Interscicnce Conference on Antimicrobial Agents and Chemotherapy; 1991 Sep 29-Oct 2: Chicago, Illinois. Washington DC, American Society for Microbiology: 106
68. Quick RH, Hoge CW, Hamilton DJ, et al. Underutilization of pneumococcal vaccine in nursing homes in Washington state: report of a serotype-specific outbreak and a survey. Am J Med 1993; 94: 149-52
69. Outbreaks of pneumococcal pneumonia among unvaccinated residents in chronic-care facilities - Massachusetts, October 1995, Oklahoma, February 1996, and Maryland, May-June 1996. MMWR 1997; 46 (3): 60-2
70. Butler JC, Breiman RF, Campbell JF, et al. Polysaccharide pneumococcal vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270: 1826-31
71. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453-60
72. Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly-people. JAMA 1997; 278: 1333-9